ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate1 short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.
The easy-to-implement solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.
ProFound AI Risk uniquely combines a range of risk factors, offering superior performance and accuracy in assessing short-term risk compared to traditional, commonly-used breast cancer risk models.1
Superior AccuracyAn AUC3 of 0.83 offers greater accuracy compared to traditional risk assessment models.1,2Simplified WorkflowEfficient and easy to implement solution provides a rapid short-term risk estimate based on the mammographic exam.Personalized CareImproved model delivers operational efficiency and enhances patient care.
The latest generation of ProFound AI Risk offers unprecedented insights for clinicians and patients
Some women have a higher risk of developing breast cancer based on their geographical location and ancestry. With ProFound AI Risk, patient care has never been more personalized.
Specifically designed to factor in racial and ethnic backgrounds, ProFound AI Risk offers an equitable and inclusive approach to precision screening.1,4 The algorithm also factors in clinically relevant global screening guidelines and more than 15 country incidence and mortality reference tables, for alignment with that country’s general population.
ProFound AI Risk also includes multiple risk factors found in a screening mammogram:
AgeBreast DensitySubtle Mammographic Features
Ethnically-Inclusive Risk Assessment Matters
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.